Is Cambium Bio Ltd halal to invest in?

As of July 2026, Cambium Bio Ltd CMB.AX is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Cambium Bio Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Cambium Bio Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Cambium Bio Ltd?

Muslim investors may consider investing in Cambium Bio Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Cambium Bio Ltd classified as HALAL?

Musaffa determines the Shariah status of Cambium Bio Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Cambium Bio Ltd updated?

The Shariah compliance status of Cambium Bio Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Cambium Bio Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Cambium Bio Ltd?

You can check the latest Shariah compliance status of Cambium Bio Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Cambium Bio Ltd CMB.AX

Last Updated: Jul 21, 12:00 AM·ASX

CMB.AX Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Cambium Bio Ltd is classified as halal.

HALAL

Report Source: 2025 2nd Quarter Report

Cambium Bio Ltd. Stock Analysis CMB.AX

Australia Health Care Nano Cap Report: Q2, 2025

Cambium Bio Ltd. engages in the development and commercialization of regenerative therapies derived from novel processed human platelets. The firm's proprietary technology, based on human platelet lysate, is being leveraged to create a pipeline of novel therapeutics, with a primary focus on ophthalmology. The Company’s lead product candidate, Elate Ocular, is being developed to address significant unmet medical needs in the treatment of dry eye disease. The company contains enriched levels of regenerative factors, protease inhibitors, minerals and vitamins. In addition, the Company's stem cell platform, Progenza, is being applied to the development of therapies for knee osteoarthritis and other tissue repair indications. The company is also developing Sygenus, a preclinical secretome-based biologic for wound healing.

Key Statistics of Cambium Bio Ltd (CMB.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.41AUD0.41

Today's Open

AUD0.41

Volume

1254.00

P/E Ratio (TTM)

52 Week Range

AUD0.26AUD0.60

Market Cap

11.89M

Avg. Volume

13.75K

Dividend Yield

Financial Metrics & Statements of Cambium Bio Ltd (CMB.AX)

Super Investors Invested in Cambium Bio Ltd (CMB.AX)

FAQ's for Cambium Bio Ltd (CMB.AX)

As of July 2026, Cambium Bio Ltd CMB.AX is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Cambium Bio Ltd using these criteria to determine its compliance status.
Muslim investors may consider investing in Cambium Bio Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Cambium Bio Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Cambium Bio Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Cambium Bio Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.